This inventor holds 2 USPTO granted patents. Top assignees: Ucb S.a., Ucb, S.a./n.v.. Active years: 2004-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2005
Title: The Innovations of Jeremy Kintigh
Introduction
Jeremy Kintigh is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrrolidinone derivatives. With a total of 2 patents, Kintigh's inventions are aimed at addressing critical medical conditions.
Latest Patents
Kintigh's latest patents focus on pyrrolidinone derivatives. The present invention provides pharmaceutical compositions and novel compounds useful in the treatment of conditions mediated by CCR2, MCP-1, or the interaction thereof. The compounds of the present invention are pyrrolidinones and pyrrolidine-thiones. This innovative approach has the potential to impact the treatment landscape for various medical conditions.
Career Highlights
Throughout his career, Kintigh has worked with notable companies such as UCB, S.A./N.V. and UCB S.A. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in pharmaceutical science.
Collaborations
Kintigh has collaborated with talented individuals in his field, including Dong Zou and Olivier Dasse. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Jeremy Kintigh's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents and collaborations highlight the importance of research and development in creating effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile